Biometric and refractive data
| Characteristic | N | Mean±SD (range) |
|---|---|---|
| Axial length (mm) | 68 | 23.55±1.18 (21.58/27.73) |
| K1 (D) | 68 | 43.16±1.54 (39.52/46.94) |
| K2 (D) | 68 | 44.29±1.71 (40.37/48.21) |
| CDVA preop (logMar) | 62 | 0.41±0.47 (−0.10/3.00) |
| Manifest SE preop (D) | 62 | −0.15±2.90 (−9.63/5.13) |
| Aphakia aberrometry 1/3 (M5) | ||
| SE (D) | 67 | 13.41±2.49 (5.27/17.10) |
| J0 (D) | 67 | −0.05±0.71 (−1.00/1.93) |
| J45 (D) | 67 | −0.05±0.66 (−2.27/1.73) |
| B (D) | 67 | 13.44±2.48 (5.28/17.17) |
| Aphakia aberrometry 2/3 (M6) | ||
| SE (D) | 38 | 12.59±3.58 (−2.29/16.90) |
| J0 (D) | 38 | 0.01±0.74 (−1.00/1.89) |
| J45 (D) | 38 | −0.04±0.47 (−0.78/1.49) |
| B (D) | 38 | 12.75±3.07 (2.50/16.90) |
| Aphakia aberrometry 3/3 (M7) | ||
| SE (D) | 32 | 12.83±2.61 (7.65/17.25) |
| J0 (D) | 32 | 0.09±0.70 (−0.91/1.71) |
| J45 (D) | 32 | −0.16±0.42 (−0.90/0.67) |
| B (D) | 32 | 12.86±2.60 (7.70/17.27) |
| Implanted IOL power (D) | 69 | 21.54±3.81 (7.50/28.00) |
| Adjusted IOL power (D) | 64 | 21.23±3.45 (8.42/27.50) |
| CDVA postop at 3 months (logMar) | 65 | 0.18±0.26 (−0.10/1.30) |
B, blurring strength as defined by Thibos and Horner.11
N differs across the three measurement points (labelled M5, M6 and M7) because of measurement failure in some instances.
CDVA preop, corrected distance visual acuity preoperatively; D, dioptre; J0, J45, Jackson cross-cylinder at 0° and 45°, respectively; IOL, intraocular lens; SE, spherical equivalent.